T2 Biosystems Inc
TTOO
Market Cap$49.59M
Close$
$3.41
39.6% downside
Current Fair Value
39.6% downsideOvervalued by 39.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $49.59 Million |
|---|---|
| Enterprise Value | $97.65 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-11.86 |
| Beta | 1.36 |
| Outstanding Shares | 8,792,950 |
| Avg 30 Day Volume | 655,485 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.09 |
|---|---|
| PEG | 4.41 |
| Price to Sales | - |
| Price to Book Ratio | -1.13 |
| Enterprise Value to Revenue | 13.61 |
| Enterprise Value to EBIT | -2.12 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.56 |
| Debt to Equity | -1.44 |
Revenue Sources
No data
ESG Score
No data
About T2 Biosystems Inc
CEO: John Sperzel